StockData
Veradermics, Inc logo

Veradermics, Inc (MANE) income statement

MANENYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$124.86−0.78 (-0.62%)

Close on Nov 18, 2026Market cap $5.22BP/E –Yield –

Veradermics, Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
82.6%

Financial strength

Current ratio
70.53
Debt to equity
–
Debt to assets
–
Cash to current liabilities
2730.7%

Valuation

P/E ratio
–
Price to sales
–
Price to book
6.41
Dividend yield
–

See a number that looks wrong?